Tranxene and Vesicare drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tranxene (clorazepate dipotassium) and Vesicare (solifenacin succinate). Common drug interactions include diverticulitis among females and visual impairment among males.

The phase IV clinical study analyzes what interactions people have when they take Tranxene and Vesicare. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Tranxene?

Tranxene has active ingredients of clorazepate dipotassium. It is often used in stress and anxiety. eHealthMe is studying from 6,550 Tranxene users. Check the latest studies of Tranxene.

What is Vesicare?

Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,656 Vesicare users. Check the latest studies of Vesicare.

On Jul, 14, 2026

14 people who take Tranxene and Vesicare together, and have interactions are studied.

Tranxene and Vesicare drug interactions.

What are the common drug interactions of Tranxene and Vesicare, by gender? *:

female:

Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Drug ineffective
Dysuria (painful or difficult urination)
Flatulence (flatus expelled through the anus)
Hallucination (an experience involving the perception of something not present)
Interstitial lung disease
Intervertebral disc disorder (spinal disc disorder)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
Respiratory distress (difficulty in breathing)

male:

Visual impairment
Confusional state

What are the common drug interactions of Tranxene and Vesicare, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Hepatocellular injury (liver injury)

40-49:

n/a

50-59:

Cystitis (inflammation of the wall of the bladder)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Intervertebral disc disorder (spinal disc disorder)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)

60+:

Visual impairment
Bladder neoplasm (bladder tumour)
Interstitial lung disease
Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
Colon cancer
Confusional state
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Drug ineffective

What are the existing conditions these people have? *

Constipation: 6 people, 42.86%
Birth Control: 5 people, 35.71%
Urinary Tract Infection: 1 person, 7.14%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 7.14%
Pain: 1 person, 7.14%
Osteomyelitis (infection of bone): 1 person, 7.14%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 1 person, 7.14%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Gait Disturbance: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Tranxene and Vesicare?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously